This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Low Grade Glioma
Information about Low Grade Glioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Low Grade Glioma
Most recent studies have shown that Low Grade Glioma shares some biological mechanisms with anaplastic-astrocytoma, astrocytoma, brain-neoplasms, epilepsy, glioblastoma, glioblastoma-multiforme, glioma, malignant-glioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, meningioma, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nervousness, oligodendroglioma, pilocytic-astrocytoma, supratentorial-neoplasms, tumor-progression.
Among the many pathways, these few ones have gauged particular interests from scientists studying Low Grade Glioma, and have been seen in publications frequently: Amino Acid Transport, Angiogenesis, Cell Cycle, Cell Differentiation, Cell Growth, Cell Migration, Cell Proliferation, Cognition, Dna Repair, Growth Hormone Secretion, Hypersensitivity, Immune Response, Localization, Methylation, Oncogenesis, Pathogenesis, Response To Radiation, Secretion, Segmentation, Transport
Quite a number of genes have been found to play important roles in Low Grade Glioma, such as CALB2, CD55, CDKN2A, CR2, CSF2, DHRS4, EGFR, GFAP, IDH1, LAMC2, MAPK3, MGMT, MID1, PLAU, POMT1, TDGF1, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.